Sign in
4

Changes in Ownership

Nuvectis Pharma, Inc. Filed Acc 0001104659-22-042815

Chief Science & Business Off acquired 60,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Poradosu Enrique · Chief Science & Business Off

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2022-04-01 Grant or award : show line 1 in the form +60,000 1,257,649 D
Loading xslF345X03/tm2211420-3_4seq1.xml…